跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Enoxfadz 4000 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Enoxfadz 4000
Approved
STANDARD
Enoxfadz 4000
Brawn Laboratories Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4fe69a7c033fac02
Company
Brawn Laboratories Ltd.
Type
Standard
Approval Details
Approval Id
4fe69a7c033fac02
Drug Approval Philippines Name
Enoxfadz 4000
Product Name
Enoxfadz 4000
Registration Number
BRP-041-17
Brand Name
Enoxfadz 4000
Generic Name
Enoxaparin sodium
Dosage Form
Solution for Injection (SC)
Dosage Strength
4000 IU Anti-Factor Xa (Equivalent to 40 mg) / 0.4 mL
Manufacturer
Brawn Laboratories Ltd.
Importer
Ambica International Corporation
Distributor
FADZ Pharma Inc.
Issuance Date
24 January 2025
Expiry Date
09 December 2025
Pharmacologic Category
Anticoagulant
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4fe69a7c033fac02
Type
Standard
Back to Philippines FDA Approvals